TrialGenetics in medicine : official journal of the American College of Medical Genetics2021

Safety and efficacy of low-dose PI3K inhibitor taselisib in adult patients with CLOVES and Klippel-Trenaunay syndrome (KTS): the TOTEM trial, a phase 1/2 multicenter, open-label, single-arm study.

M Luu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.